• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, November 19, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.

A story by BestLife referenced a study published in a supplement to AJMC®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.

Related Videos
Tom Kim, chief medical officer, Sound Long-Term Care Management
Dr Yara Abdou
Erika Hamilton, MD
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Related Content
The key takeaways from AAD 2025 include expert insights on topical JAK safety, climate-driven skin challenges, tech innovation, and expanding equitable access in dermatology.

ICYMI: Highlights From AAD 2025

December 25th 2025
Article

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, affordability of classic therapies, and advancing AI in dermatology.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

Explore this year’s top heart failure insights—from new FDA approvals to emerging risk markers and value-based care strategies shaping patient outcomes.

Top 5 Most-Read Heart Failure Content of 2025

December 23rd 2025
Article

Our top 5 heart failure content of 2025 include FDA approvals, GDMT optimization, risk markers like LBBB and SDOH, and value-based care models improving outcomes in heart failure.

Read More

managed care cast logo

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

November 18th 2025
Podcast

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

FDA approval with stamp. | Image Credit: Surendra – stock.adobe.com

FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy

December 22nd 2025
Article

The cardiac myosin inhibitor is expected to be available in the US in the second half of January 2026.

Read More

AJMC original research managerial

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

December 22nd 2025
Article

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.